Scientific Symposium I. Emerging Research Tools in Lung Cancer
Channel 1
Chair: Wan Seop Kim (Korea)
Time	Topic	Speaker
08:00-08:25	Extracellular Vesicle DNA Liquid Biopsy	Jae Young Hur (Korea)VOD
08:25-08:50	Multiplex Molecular and Histopathology in Lung Cancer	Tae Jung Kim (Korea)VOD
08:50-09:15	Liquid Biopsy Approaches for EGFR Mutant NSCLC Patients	Therese Becker (Australia)VOD
09:15-09:40	Break

Satellite Symposium I. MSD Korea Ltd
Channel 1, 2, 3
Chair: Young Chul Kim (Korea)
Time	Topic	Speaker
09:50-10:40	"Turn Your Face To Hope For The Patients": Pembrolizumab in the 1st-line metastatic squamous NSCLC	Sun Min Lim (Korea)VOD

Oral Presentation I.
Channel 1
Chair: Seung Joon Kim (Korea)
Time	Topic	Speaker
10:50-11:00	TUMOR SPREAD THROUGH AIR SPACES (STAS): PROGNOSTIC SIGNIFICANCE OF GRADING IN NON-SMALL CELL LUNG CANCER : CAN STAS BE A T FACTOR IN LUNG ADENOCARCINOMA?	Yeon Bi Han (Korea)VOD
11:00-11:10	BALF LIQUID BIOPSY PROVIDES A NOVEL PLATFORM FOR SPEEDY AND ACCURATE EGFR MUTATION TESTING IN ADVANCED NSCLC PATIENTS	In Ae Kim (Korea)VOD
11:10-11:20	DECONSTRUCTING THE INTRA-TUMOR SUBCLONAL HETEROGENEITY, ALLEL-SPECIFIC HLA LOSS AND IMMUNE ESCAPE OF LUNG SYNCHRONOUS ADENOCARCINOMAS PRESENTING AS GROUND-GLASS NODULES USING WHOLE GENOME SEQUENCING	Yijiu Ren (China)VOD
11:20-11:30	MMP1/9/10/11/15 AS POTENTIAL TARGETS AND MMP12/13/14/28 AS NEW BIOMARKERS FOR THE PROGNOSIS OF HUMAN LUNG CANCER	Yujie Deng (China)VOD
11:30-11:40	EGFR ANALYSIS OF MULTIPLE LUNG CANCER: CLINICOPATHOLOGIC REVIEW	Hyunwoo Lee (Korea)VOD
11:40-11:50	PREDICTING CLINICAL OUTCOMES IN LUNG CANCER PATIENTS AFTER IMMUNE CHECKPOINT INHIBITOR: A COMPARISON BETWEEN SEMIAUTOMATIC SOFTWARE AND RECIST	Jehun Kim (Korea)VOD
11:50-12:00	COMPARISON OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR PATIENTS WITH LUNG ADENOCARCINOMA HARBORING DIFFERENT EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION TYPES	Sojung Park (Korea)VOD
12:00-12:10	THE IMPACT OF PROGRAMMED DEATH-LIGAND 1 EXPRESSION ON THE PROGNOSIS OF EARLY-STAGE RESECTED NON-SMALL CELL LUNG CANCER: A META-ANALYSIS OF LITERATURES.	Shuai Zhu (China)VOD
12:10-12:20	CIRCULATING TUMOR CELLS AND PERIPHERAL BLOOD CELLS AS PREDICTIVE MARKERS FOR IMMUNOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER	Cheol-Kyu Park (Korea)VOD
12:20-12:30	FUNCTIONAL ROLE OF COMPOUND EGFR MUTATION AND ITS POTENTIAL PREDICTIVE VALUE ON ARCHIVAL TUMOR TISSUES OF THE LUNG ADENOCARCINOMA PATIENTS HARBORING EGFR MUTATIONS.	Seo Ree Kim (Korea)VOD

Oral Presentation II.
Channel 1
Chair: Sei Hoon Yang (Korea)
Time	Topic	Speaker
12:40-12:50	CT MEAN DENSITY IS ASSOCIATED WITH PATHOLOGICAL INVASION FOR PURE GROUND-GLASS NODULES	Jian Zhang (China)VOD
12:50-13:00	DEVELOPMENT AND VALIDATION OF MACHINE LEARNING-BASED MODEL FOR THE PREDICTION OF MALIGNANCY IN MULTIPLE PULMONARY NODULES: ANALYSIS FROM MULTICENTRIC COHORTS	Yuntao Nie (China)VOD
13:00-13:10	CORRELATION OF EGFR STATUS WITH CHEST CT SCAN FINDINGS AMONG PATIENTS WITH NON-SMALL CELL LUNG ADENOCARCINOMA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY	Jestoni Aranilla (Philippines)VOD
13:10-13:20	LUNG CANCER PROBABILITY AND CLINICAL OUTCOMES OF BASELINE AND NEW SUBSOLID NODULES DETECTED ON LOW-DOSE COMPUTED TOMOGRAPHY SCREENING	Yeon Wook Kim (Korea)VOD
13:20-13:30	RADIOLOGIC AND CLINICAL FEATURES OF SCREENING-DETECTED PULMONARY INVASIVE MUCINOUS ADENOCARCINOMA	Dae Hyeon Kim (Korea)VOD
13:30-13:40	CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WITH NON-SMOKING SMALL CELL LUNG CANCER IN KOREA	Hye Seon Kang (Korea)VOD
13:40-13:50	A NATIONAL ANALYSIS OF THE MANAGEMENT AND OUTCOMES FOR PATIENTS WITH PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA	Deven Patel (USA)VOD
13:50-14:00	USEFULNESS OF PULMONARY REHABILITATION IN NON-SMALL CELL LUNG CANCER BY ANALYZING PULMONARY FUNCTION TEST AND CHEST COMPUTED TOMOGRAPHY	Juwhan Choi (Korea)VOD
14:00-14:10	USING PATIENT-REPORTED OUTCOMES TO MANAGE POSTOPERATIVE SYMPTOMS IN PATIENTS WITH LUNG CANCER: A MULTICENTER, RANDOMISED CONTROLLED TRIAL	Wei Dai (China)VOD

Satellite Symposium II. Pfizer Ltd.
Channel 1
Chair: Jin Seok Ahn (korea)
Time	Topic	Speaker
14:30-14:55	Selecting Optimal 1L therapy in EGFR + NSCLC : New perspectives for Dacomitinib	Ki Hyeong Lee (Korea)VOD

Satellite Symposium III. Ono Pharma Korea / BMS Korea
Channel 1
Chair: Ji Youn Han (korea)
Time	Topic	Speaker
14:55-15:20	Better the Last Smile than the First Laughter	Hyun Ae Jung (Korea)VOD

Plenary Session I.
Channel 1, 2, 3
Chair: Young Tae Kim (Korea)
Time	Topic	Speaker
16:20-17:00	Clonal Heterogeneity and Lung Cancer Evolution: Lung TRACERx	Charles Swanton (UK)VOD

Plenary Session II.
Channel 1, 2, 3
Chair: Jeong Seon Ryu (Korea)
Time	Topic	Speaker
17:10-17:50	10-Year and Beyond Results in NELSON Lung Cancer Screening Study	Harry J. de Koning (Netherlands)VOD

Education Session I. Interventional Bronchoscopy for Cancers
Channel 2
Chair: Choon Taek Lee (Korea)
Time	Topic	Speaker
08:00-08:25	Functional Bronchoscopy	Lutz Freitag (Switzerland)VOD
08:25-08:50	Medical Thoracoscopy: Advances and Increasing Role in Lung Cancer	Pyng Lee (Singapore)VOD
08:50-09:15	Management of Central Airway Obstruction	Hojoong Kim (Korea)VOD
09:15-09:40	Lung biopsy: How to Overcome the Limitations	Dongil Park (Korea)VOD

Satellite Symposium I. MSD Korea Ltd
Channel 1, 2, 3
Chair: Young Chul Kim (Korea)
Time	Topic	Speaker
09:50-10:40	"Turn Your Face To Hope For The Patients": Pembrolizumab in the 1st-line metastatic squamous NSCLC	Sun Min Lim (Korea)VOD

Education Session II. SCLC and other thoracic malignancies
Channel 2
Chair: Sung yong Lee (Korea)
Time	Topic	Speaker
10:50-11:15	Incorporation of Immuno-oncology in SCLC	Sehoon Lee (Korea)VOD
11:15-11:40	Novel Therapeutic Approaches in SCLC	Gyeong Won Lee (Korea)VOD
11:40-12:05	Recent Update in Thymic Malignancy Treatment	Se Hyun Kim (Korea)VOD
12:05-12:30	Current standard and novel therapeutic options of malignant mesothelioma	Ji Hyun Park (Korea)VOD

Education Session IV. Expanding the Surgical Indication in Lung Cancer
Channel 2
Chair: In Kyu Park (Korea)
Time	Topic	Speaker
12:40-13:05	Salvage Operation after Definitive CCRTx	Jessica Donington (USA)VOD
13:05-13:30	Salvage Surgery for Advanced Non-small Cell Lung Cancer after Targeted Therapy	Tomoyuki Hishida (Japan)VOD
13:30-13:55	Experience of Pulmonary Resection after Immunotherapy	Seong Yong Park (Korea)VOD
13:55-14:20	Pulmonary Resection after Neoadjuvant Therapy	Hong Kwan Kim (Korea)VOD

Multidisciplinary Symposium. SABR versus Surgery for Early Lung Cancer
Channel 2
Chair: Dong Kwan Kim (Korea)
Time	Topic	Speaker
14:30-14:55	Review of SABR versus Surgery Trials	Hong Gyun Wu (Korea)VOD
14:55-15:20	Surgery as a Primary Treatment for Early Lung	Masatsugu Hamaji (Japan)VOD
15:20-15:45	SABR as a Primary Treatment for Early Lung Cancer	Jaeho Cho (Korea)VOD
15:45-16:10	Combination of SABR and Immunotherapy for Lung Cancer	Joe Y. Chang (USA)VOD

Plenary Session I.
Channel 1, 2, 3
Chair: Young Tae Kim (Korea)
Time	Topic	Speaker
16:20-17:00	Clonal Heterogeneity and Lung Cancer Evolution: Lung TRACERx	Charles Swanton (UK)VOD

Plenary Session II.
Channel 1, 2, 3
Chair: Jeong Seon Ryu (Korea)
Time	Topic	Speaker
17:10-17:50	10-Year and Beyond Results in NELSON Lung Cancer Screening Study	Harry J. de Koning (Netherlands)VOD

KASTT Joint Session. Upcoming era of combination treatment for advanced EGFR mutated lung adenocarcinomas
Channel 3
Chair: Min Ki Lee (Korea)
Time	Topic	Speaker
08:00-08:25	Rationale of front line combination treatment for EGFRm+ NSCLC	Seong Hoon Yoon (Korea)VOD
08:25-08:50	Up-to-date of cytotoxic chemo-TKI combination	Myoung kyu Lee(Korea)VOD
08:50-09:15	Up-to-date of non-cytotoxic agent-TKI combination	Hye Ryoun Kim (Korea)VOD
09:15-09:40	Final report of granted KASTT research	Sung yong LeeVOD Chang Min Choi (Korea)VOD

Satellite Symposium I. MSD Korea Ltd
Channel 1, 2, 3
Chair: Young Chul Kim (Korea)
Time	Topic	Speaker
09:50-10:40	"Turn Your Face To Hope For The Patients": Pembrolizumab in the 1st-line metastatic squamous NSCLC	Sun Min Lim (Korea)VOD

Education Session III. Treatment of N2-Positive Lung Cancer
Channel 3
Chair: Deog Gon Cho (Korea)
Time	Topic	Speaker
10:50-11:15	Updates on the Mediastinal Staging	Bin Hwangbo (Korea)VOD
11:15-11:40	Role of Surgery in N2 Diseases	Takahiro Nakajima (Japan)VOD
11:40-12:05	Neoadjuvant Treatment for N2 Disease; from Chemotherapy to Immunotherapy and TKI	Min Hee Hong (Korea)VOD
12:05-12:30	Role of Postoperative Radiotherapy in Resected N2 Disease	Byoung Hyuck Kim (Korea)VOD

Education Session V. Advances in Radiation Oncology
Channel 3
Chair: Hong Gyun Wu (Korea)
Time	Topic	Speaker
12:40-13:05	Circulating Tumor DNA as a Therapeutic Marker after Radiotherapy	Scott Bratman (Canada)VOD
13:05-13:30	Combining of Radiotherapy with Immunotherapy in NSCLC	Joo Ho Lee (Korea)VOD
13:30-13:55	Optimal Application of Proton Therapy for Lung Cancer	Jae Myoung Noh (Korea)VOD
13:55-14:20	Radiomics with Artificial Intelligence in Radiation Oncology	Hidetaka Arimura (Japan)VOD

MSIO Joint Session. Immunotherapy in different clinical situations: What's the optimal approach?
Channel 3
Chair: Sang We Kim(Korea)
Time	Topic	Presenter & Panels
14:30-15:10	Case 1. Newly diagnosed advanced and metastatic adenocarcinoma of the lung	Dae Ho Lee(Korea) and to be determinedVOD
15:10-15:40	Case 2. Newly diagnosed locally advanced non-small cell lung cancer but multiple nodal stations	Dae Ho Lee(Korea) and to be determinedVOD
15:40-16:10	Case 3. Newly diagnosed early lung cancer but comorbidities	Dae Ho Lee(Korea) and to be determinedVOD

Plenary Session I.
Channel 1, 2, 3
Chair: Young Tae Kim (Korea)
Time	Topic	Speaker
16:20-17:00	Clonal Heterogeneity and Lung Cancer Evolution: Lung TRACERx	Charles Swanton (UK)VOD

Plenary Session II.
Channel 1, 2, 3
Chair: Jeong Seon Ryu (Korea)
Time	Topic	Speaker
17:10-17:50	10-Year and Beyond Results in NELSON Lung Cancer Screening Study	Harry J. de Koning (Netherlands)VOD